Since its introduction in 2005, the complications attributed to the use of Byetta continue to increase by leaps and bounds. From mild side effects ranging from allergic reactions to headaches, it has progressed to more severe conditions such as pancreatitis and serious kidney problems. Recently, a report by the Institute of Safe Medication Practices (ISMP) was released showing that continued use of the Byetta injectable drug to treat type 2 diabetes may result to increased risk of getting pancreatic cancer.
The findings of the research, based on the adverse reports gathered by the Food and Drug Administration (FDA), indicated that in a span of one year, around 105 patients reported to have developed pancreatic cancer as compared to only two patients who used other types of diabetes medications.
As if this was not enough, findings of a new study conducted Dr. Peter Butler, as published in the medical journal Gastroenterology, also revealed that the use of the Byetta medication may significantly increase the risk of thyroid cancer among type 2 diabetes patients. Another publication, the GI & Hepatology News, reported its findings that the risk of thyroid cancer was very high with an unsatisfactory odds ratio of 4.7.
Read More: Study: Byetta Linked to Cancer Risks